Filing Details
- Accession Number:
- 0001209191-19-034219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-04 16:08:42
- Reporting Period:
- 2019-06-01
- Accepted Time:
- 2019-06-04 16:08:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1643921 | N. Sangeeta Bhatia | C/O Vertex Pharmaceuticals Incorporated Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-06-01 | 2,381 | $0.00 | 7,260 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2019-06-03 | 400 | $166.52 | 6,860 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-06-03 | 320 | $167.78 | 6,540 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.
- Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $166.52 (range $165.91 to $166.86).
- Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $167.78 (range $167.00 to $168.42).
Billionaire Hedge Funds
